At Orchid Cellmark, we're building a company that we believe will be able to take advantage of the emerging trends in the growing global idenity DNA testing market. We think that our path to growth is sound and our mission clear: Capitalize on the opportunities of today while developing the vision and strengths to tap the potential of tomorrow, always with a view towards building shareholder value. Our Investor Relations Department is committed to providing comprehensive and useful company information and other services of value to our current and prospective investors. Please contact us with any questions, requests or feedback you may have about our company and our web site.

Please note that any opinions, estimates or forecasts regarding our historical or predicted performance made by the analysts at these firms are theirs alone and do not represent opinions, forecasts or predictions of Orchid Cellmark or its management. Orchid Cellmark is providing this listing as a service to its stockholders, and does not by listing these firms imply its endorsement of or concurrence with such information, conclusions or recommendations. Some of these firms may be market-makers in Orchid Cellmark stock and/or hold other long or short positions in the stock, and may provide compensated services to Orchid Cellmark.